Chemotherapy with dacarbazine and 5-fluorouracil in advanced medullary thyroid cancer.
暂无分享,去创建一个
L. Dogliotti | A. Berruti | A. Angeli | F. Orlandi | B. Puligheddu | P. Caraci | G. Pivano | Fabio Orlandi | Alberto Angeli
[1] R. Labianca,et al. Treatment of metastatic carcinoids and other neuroendocrine tumors with recombinant interferon‐alpha‐2a: A study by the Italian trials in Medical Oncology Group , 1993, Cancer.
[2] J. Farndon,et al. Medullary thyroid carcinoma , 1993, The British journal of surgery.
[3] H. Dralle,et al. Prognostic factors in medullary thyroid carcinomas. , 1989, Hormone and metabolic research. Supplement series.
[4] S. Wells,et al. Advances in the diagnosis and treatment of medullary thyroid carcinoma. , 1987, The Surgical clinics of North America.
[5] D. Schoenfeld,et al. A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma , 1985, Cancer.
[6] A. Kessinger,et al. Therapy of malignant APUD cell tumors: Effectiveness of DTIC , 1983, Cancer.
[7] W. Taylor,et al. The Surgical Management of Medullary Thyroid Carcinoma , 1983, Annals of surgery.
[8] J. Hanley,et al. Streptozocin alone compared with streptozocin plus fluorouracil in the treatment of advanced islet-cell carcinoma. , 1980, The New England journal of medicine.